| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 59.012.127 $ | 99,54 | 3.545.862 | |||||||
| IMMUNITYBIO INC | IMMUNITYBIO INC COM | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 2.847.136 $ | 4,80 | 401.005 | |
| APELLIS PHARMACEUTICALS INC | APELLIS PHARMACEUTICALS INC COM | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 1.535.994 $ | 2,59 | 37.509 | |
| KALVISTA PHARMACEUTICALS INC | KALVISTA PHARMACEUTICALS INC COM | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 1.492.000 $ | 2,52 | 55.964 | |
| MODERNA INC | MODERNA INC COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 1.475.685 $ | 2,49 | 32.122 | |
| IOVANCE BIOTHERAPEUTICS INC | IOVANCE BIOTHERAPEUTICS INC COM | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 1.445.361 $ | 2,44 | 430.167 | |
| MIRUM PHARMACEUTICALS INC | MIRUM PHARMACEUTICALS INC COM | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 1.416.639 $ | 2,39 | 14.558 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUTICS INC COM | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 1.326.692 $ | 2,24 | 6.386 | |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC ORD SHS CL A | EC | GB00BRXB0C07 | Long | Börsenkurs (Stufe 1) | 1.223.710 $ | 2,06 | 22.754 | |
| ROIVANT SCIENCES LTD | ROIVANT SCIENCES LTD SHS | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 1.221.683 $ | 2,06 | 42.821 | |
| ZAI LAB LTD | ZAI LAB LTD ADR | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 1.152.460 $ | 1,94 | 53.256 | |
| LIGAND PHARMACEUTICALS | LIGAND PHARMACEUTICALS INC | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 1.145.414 $ | 1,93 | 4.992 | |
| BIOCRYST PHARMACEUTICALS INC | BIOCRYST PHARMACEUTICALS INC COM | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 1.145.137 $ | 1,93 | 125.015 | |
| TRAVERE THERAPEUTICS INC | TRAVERE THERAPEUTICS INC COM | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 1.144.400 $ | 1,93 | 27.170 | |
| NOVAVAX INC | NOVAVAX INC COM NEW | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 1.141.549 $ | 1,93 | 144.044 | |
| UNITED THERAPEUTICS CORP | UNITED THERAPEUTICS CORP | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 1.093.564 $ | 1,84 | 1.914 | |
| GERON CORP | GERON CORP COM | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 1.071.626 $ | 1,81 | 695.861 | |
| BIONTECH SE | BIONTECH SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 1.032.534 $ | 1,74 | 9.981 | |
| AMGEN INC | AMGEN INC COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 1.030.786 $ | 1,74 | 2.977 | |
| EXELIXIS INC | EXELIXIS INC | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 1.029.160 $ | 1,74 | 23.148 | |
| BIOGEN INC | BIOGEN INC | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.028.548 $ | 1,73 | 5.434 | |
| GILEAD SCIENCES INC | GILEAD SCIENCES INC | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 1.028.272 $ | 1,73 | 7.859 | |
| TG THERAPEUTICS INC | TG THERAPEUTICS INC COM | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 1.019.717 $ | 1,72 | 30.187 | |
| KRYSTAL BIOTECH INC | KRYSTAL BIOTECH INC COM | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 1.013.897 $ | 1,71 | 3.866 | |
| LEGEND BIOTECH CORP | LEGEND BIOTECH CORP SPONSORED ADS | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 997.201 $ | 1,68 | 42.398 | |
| SYNDAX PHARMACEUTICALS INC | SYNDAX PHARMACEUTICALS INC COM | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 995.574 $ | 1,68 | 46.457 | |
| ARROWHEAD PHARMACEUTICALS INC | ARROWHEAD PHARMACEUTICALS INC COM | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 992.053 $ | 1,67 | 13.501 | |
| ASCENDIS PHARMA A/S | ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 984.728 $ | 1,66 | 4.293 | |
| AGIOS PHARMACEUTICALS INC | AGIOS PHARMACEUTICALS INC | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 971.684 $ | 1,64 | 34.703 | |
| HALOZYME THERAPEUTICS INC | HALOZYME THERAPEUTICS INC | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 968.332 $ | 1,63 | 15.211 | |
| ARDELYX INC | ARDELYX INC COM | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 964.648 $ | 1,63 | 152.393 | |
| BIOMARIN PHARMACEUTICAL INC | BIOMARIN PHARMACEUTICAL INC | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 956.903 $ | 1,61 | 17.750 | |
| INCYTE CORP | INCYTE CORP | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 944.888 $ | 1,59 | 9.918 | |
| AURINIA PHARMACEUTICALS INC | AURINIA PHARMACEUTICALS INC COM | EC | 05156V102 | Long | Börsenkurs (Stufe 1) | 918.592 $ | 1,55 | 59.707 | |
| SAREPTA THERAPEUTICS INC | SAREPTA THERAPEUTICS INC | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 917.780 $ | 1,55 | 43.955 | |
| REGENERON PHARMACEUTICALS | REGENERON PHARMACEUTICALS INC | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 902.209 $ | 1,52 | 1.276 | |
| BRIDGEBIO PHARMA INC | BRIDGEBIO PHARMA INC COM | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 895.417 $ | 1,51 | 12.592 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 894.506 $ | 1,51 | 2.093 | |
| BEONE MEDICINES LTD | BEONE MEDICINES LTD SPONSORED ADS | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 875.476 $ | 1,48 | 2.965 | |
| IONIS PHARMACEUTICALS INC | IONIS PHARMACEUTICALS INC | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 875.290 $ | 1,48 | 11.708 | |
| CRISPR THERAPEUTICS AG | CRISPR THERAPEUTICS AG NAMEN AKT | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 873.816 $ | 1,47 | 16.695 | |
| THERAVANCE BIOPHARMA INC | THERAVANCE BIOPHARMA INC | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 871.853 $ | 1,47 | 52.082 | |
| MADRIGAL PHARMACEUTICALS INC | MADRIGAL PHARMACEUTICALS INC COM | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 856.280 $ | 1,44 | 1.655 | |
| KURA ONCOLOGY INC | KURA ONCOLOGY INC COM | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 817.649 $ | 1,38 | 92.599 | |
| NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSCIENCES INC | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 815.301 $ | 1,38 | 6.192 | |
| PTC THERAPEUTICS INC | PTC THERAPEUTICS INC COM | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 813.901 $ | 1,37 | 12.510 | |
| ACADIA PHARMACEUTICALS INC | ACADIA PHARMACEUTICALS INC COM | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 782.495 $ | 1,32 | 34.855 | |
| ARCUTIS BIOTHERAPEUTICS INC | ARCUTIS BIOTHERAPEUTICS INC COM | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 757.204 $ | 1,28 | 32.610 | |
| TARSUS PHARMACEUTICALS INC | TARSUS PHARMACEUTICALS INC COM | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 739.912 $ | 1,25 | 11.632 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 736.277 $ | 1,24 | 2.379 | |
| HARMONY BIOSCIENCES HOLDINGS INC | HARMONY BIOSCIENCES HOLDINGS INC COM | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 730.234 $ | 1,23 | 23.360 | |
| PHATHOM PHARMACEUTICALS INC | PHATHOM PHARMACEUTICALS INC COM | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 727.966 $ | 1,23 | 64.997 | |
| CRINETICS PHARMACEUTICALS INC | CRINETICS PHARMACEUTICALS INC COM | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 726.854 $ | 1,23 | 18.743 | |
| IMMUNOCORE HOLDINGS PLC | IMMUNOCORE HOLDINGS PLC ADS | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 717.678 $ | 1,21 | 25.714 | |
| RHYTHM PHARMACEUTICALS INC | RHYTHM PHARMACEUTICALS INC COM | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 677.973 $ | 1,14 | 8.333 | |
| INSMED INC | INSMED INC COM PAR $.01 | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 654.520 $ | 1,10 | 4.801 | |
| ULTRAGENYX PHARMACEUTICAL IN | ULTRAGENYX PHARMACEUTICAL INC | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 644.903 $ | 1,09 | 26.120 | |
| NUVATION BIO INC | NUVATION BIO INC COM CL A | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 499.561 $ | 0,84 | 112.261 | |
| ESPERION THERAPEUTICS INC | ESPERION THERAPEUTICS INC COM | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 491.620 $ | 0,83 | 245.810 | |
| ADMA BIOLOGICS INC | ADMA BIOLOGICS INC COM | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 490.401 $ | 0,83 | 47.844 | |
| LENZ THERAPEUTICS INC | LENZ THERAPEUTICS INC COM | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 468.487 $ | 0,79 | 52.170 | |
| OMNIAB INC | OMNIAB INC USD0.0001 A (USD12.5 VESTING) | EC | 68218J202 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 2.590 | |
| 59.012.127 $ | 99,54 | 3.545.862 |